Ominous headlines on federal cuts to biomedical research are not exaggerating the consequences. These cuts mean tangible damage to fruitful research programs, laboratories and discoveries. It takes forever (OK, only a decade or two) for most drugs to progress from basic discovery through trials to federal approval. Seemingly small delays now translate into a loss […]